Matthew D.Gobel (Matt)

Associate

(T) + 1.404.581.8280

Connect:

Share

Matt Gobel practices corporate law, with a focus on M&A and corporate governance. He advises public and private companies, as well as private equity firms, on domestic and cross-border mergers, acquisitions, corporate restructurings, and equity investments. Matt has represented clients in a wide range of industries, including energy, consumer goods, entertainment, and health care.

Experience

  • Total acquires Toshiba's interest in Freeport LNGJones Day advised Total Gas & Power Asia Private Limited ("Total"), a subsidiary of Total S.A., in (i) its purchase of all of the outstanding shares of Toshiba America LNG Corporation ("TAL") from Toshiba America, Inc. ("TAI"), and (ii) its assumption of all LNG related agreements from Toshiba Energy Systems & Solutions Corporation ("TESS").
  • Greystar completes $120 million refinancingJones Day represented Greystar Real Estate Partners, LLC, a fully-integrated property management, investment management and development and construction services company specializing in the multifamily real estate industry globally, in connection with the $120 million refinancing inclusive of a $30 million revolving credit facility and a Rule 144A offering of an additional $90 million in aggregate principal amount of Greystar’s 5.75% Senior Secured Notes due 2025.
  • Koch Equity Development invests $550 million in Getty ImagesJones Day advised Koch Equity Development, the acquisition and investment subsidiary of Koch Industries, in connection with an investment of $550 million in Getty Images.
  • Smith & Nephew acquires Ceterix® Orthopaedics Inc. for up to $105 millionJones Day advised Smith & Nephew in its acquisition of Ceterix® Orthopaedics, Inc., the developer of a unique device that addresses complex meniscal tear patterns, for up to $105 million.
  • Eastman Chemical completes $800 million notes offering, concurrent cash tender offer, and notes redemptionsJones Day represented Eastman Chemical Company, a global chemical company that manufactures and sells a broad portfolio of chemicals, plastics, and fibers, in connection with an $800 million underwritten public offering, consisting of a $300 million offering of 3.500% Notes due 2021 and a $500 million offering of 4.500% Notes due 2028.
    • View All
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.